SCHEMBL23312282

SCHEMBL23312282

c1ccc(Cc2cccc(Oc3cccc(Oc4ccccc4)c3)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 4/20 0.50
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
SRD5A2 P31213 1/20 0.50
LTA4H P09960 1/20 0.50
HPGD P15428 1/20 0.50
MAOB P27338 1/20 0.50
CALM1 P0DP23 1/20 0.50
IDH1 O75874 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MITF O75030 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
GFER P55789 1/20 0.47
NLRP1 Q9C000 1/20 0.47
NOD2 Q9HC29 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22550294 0.96 CALM1 (0.55) ALDH1A1KDM4EHTTSMN1; SMN2TSHR
SCHEMBL8896665 0.96 TSHR (0.55) ALDH1A1KDM4EHTTSMN1; SMN2TSHR
SCHEMBL9816693 0.94 SRD5A2 (0.58) ALDH1A1KDM4EHTTSMN1; SMN2TSHR
Ethylene Glycol SCHEMBL28545403 0.88 TSHR (0.51) ALDH1A1KDM4EHTTSMN1; SMN2TSHR
SCHEMBL8939741 0.87 KDM4E (0.44) ALDH1A1KDM4EHTTSMN1; SMN2TSHR
SCHEMBL21549624 0.87 MAOB (0.67) ALDH1A1SMN1; SMN2MAOBMEN1KMT2A
SCHEMBL27630414 0.87 LTA4H (0.57) ALDH1A1KDM4EHTTSMN1; SMN2SRD5A2
SCHEMBL11178465 0.83 SRD5A2 (0.51) ALDH1A1KDM4EHTTSMN1; SMN2TDP1
SCHEMBL10269397 0.82 SRD5A2 (0.68) TSHRSRD5A2LTA4HCALM1IDH1
SCHEMBL4025817 0.82 LTA4H (0.75) ALDH1A1KDM4ESMN1; SMN2TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11230520-B2 Silylations of aromatic substrates with base-activated organosilanes CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2022-01-25 US disclosed
US-20210122701-A1 SILYLATIONS OF AROMATIC SUBSTRATES WITH BASE-ACTIVATED ORGANOSILANES CALIFORNIA INSTITUTE OF TECHNOLOGY 2021-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11230520-B2 Silylations of aromatic substrates with base-activated organosilanes TYR, DDC, TPST2 ALDH1A1 1165/4885KDM4E 1154/4885HTT 3253/4885
US-20210122701-A1 SILYLATIONS OF AROMATIC SUBSTRATES WITH BASE-ACTIVATED ORGANOSILANES TYR, DDC, TPST2 ALDH1A1 1165/4885KDM4E 1154/4885HTT 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.